Therapy

Antiretroviral Therapy May Prompt Clinical MAC

Published in TB and Outbreaks Week, March 1st, 1999

Combination antiretroviral therapy may "unmask" subclinical Mycobacterium avium complex (MAC) disease, according to a report from the University of British Columbia.

To characterize the impact of combination antiretroviral therapy on the clinical and laboratory features of mycobacterial lymphadenitis, researcher P. Phillips and colleagues conducted a retrospective chart review of HIV related mycobacterial lymphadenitis at Vancouver's St. Paul's hospital between 1989 and 1997 ("Mycobacterial Lymphadenitis Associated with the Initiation of Combination Antiretroviral Therapy," Journal of AIDS and Human Retrovirology, February 1999;20(2):122-128).

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1999-03-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry